Ang,K Kian

Institution: University of Alabama, USA

Top Collaborators: Milas L, Spencer S, Trotti A, Chung CH, Raju U, Riesterer O, Harris J, Jordan R, Garden AS, Weber RS, Molkentine D, Zhang Q, Cooper JS, Lefebvre JL, Yom SS, , Thomas KP, Yang Q, Guan C, Forastiere AA

Research Interests: Head, Neck, Cancer, Patients, Epidermal Growth Factor, Radiation, Cell, Carcinoma, Human, Epidermal Growth Factor Receptor, Radiotherapy, Squamous Cell Carcinoma, Classification, Tumor, Report, Risk, Survival, Cancers, Head And Neck Cancer, Neck Cancer

Publications
Grants

Information and abstracts for author publications
Published Date	Impact	Publication
11/10/2009	22.6	The Lancet. Oncology Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.	Abstract
02/28/2011	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).	Abstract
08/31/2009	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.	Abstract
08/10/2009	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.	Abstract
05/07/2012	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.	Abstract
09/23/2012	5.6	Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.	Abstract
07/15/2009	5.6	Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Receptor signaling as a regulatory mechanism of DNA repair.	Abstract
08/15/2013	4.4	Journal of the National Comprehensive Cancer Network : JNCCN Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.	Abstract
06/03/2011	4.4	Journal of the National Comprehensive Cancer Network : JNCCN The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?	Abstract
12/02/2010	4.1	International journal of radiation oncology, biology, physics Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.	Abstract
04/27/2012	4.1	International journal of radiation oncology, biology, physics A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244).	Abstract
08/11/2009	4.1	International journal of radiation oncology, biology, physics Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.	Abstract
08/21/2010	4.1	International journal of radiation oncology, biology, physics Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.	Abstract
03/24/2009	4.1	International journal of radiation oncology, biology, physics Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.	Abstract
10/19/2012	4.1	International journal of radiation oncology, biology, physics Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis.	Abstract
06/30/2012	4.1	International journal of radiation oncology, biology, physics Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.	Abstract
04/11/2011	3.8	Journal of neural engineering Adaptive tracking of discriminative frequency components in electroencephalograms for a robust brain-computer interface.	Abstract
11/27/2008	3.7	AJNR. American journal of neuroradiology The shrinking thyroid: how does thyroid size change following radiation therapy for laryngeal cancer?	Abstract
02/02/2010	3.4	Investigational new drugs AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.	Abstract
03/19/2009	3.1	Head & neck Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.	Abstract
07/14/2009	2.3	IEEE transactions on bio-medical engineering A new discriminative common spatial pattern method for motor imagery brain-computer interfaces.	Abstract

Grants Recieved by this author
Budget Start	Budget End	Grant Type	Project Cost	Project Title
6/01/2008	7/31/2013	NIH R01: Research Project	$2,398,209	Extension of Radiotherapy Research
6/01/2008	5/31/2009	NIH P01: Research Program Projects	$238,311	MOLECULAR TARGETED COMBINED THERAPY